Parenteral Nutrition Market By Nutrition Type (Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals) and By Region - Trends, Analysis and Forecast Till 2030

Parenteral Nutrition Market accounted for USD 5.90 Billion in 2020 and is estimated to be USD 10.33 Billion by 2030 and is anticipated to register a CAGR of 5.8%.

Parenteral nutrition (PN) is the intravenous administration of nutritious items to a person, bypassing the digestive and eating processes. Pharmaceutical compounding firms create the products. The person is given a nutritional mix that includes glucose, salts, amino acids, fats, vitamins, and dietary minerals, according to a formula. When no considerable nutrition is received through other channels, it is referred to as total parenteral nutrition (TPN) or total nutritional admixture (TNA), and when nutrition is also partially enteric, it is referred to as partial parenteral nutrition (PPN). When feeding is delivered by a vein in a limb rather than a central vein, it is referred to as peripheral parenteral nutrition (PPN) (CVN). Malnutrition and cachexia are more common in cancer patients, whether they are outpatients undergoing treatment or are hospitalised.

Malnutrition caused by cancer is caused by a decrease in food intake, an increase in the requirement for energy, and a change in metabolism. [10] Patients should be screened for nutritional risks early in their cancer therapy, such as by collecting regular weights and BMI measurements. When the digestive tract cannot be accessed or is ineffective in cancer patients, parenteral nourishment is recommended.

Rising prevalence of chronic diseases

Rising prevalence of chronic diseases, including cancer and malnutrition, as well as the fast growing geriatric population and natality rate, are critical market growth drivers. Another important market driver is projected to be rising natality. Parenteral nutrition has a number of advantages, including ease of use, stimulation of stomach blood flow, efficient nutritional delivery, and muscle catabolism preservation. An increase in product demand is likely to be aided by increased understanding of these benefits. For example, educational campaigns promoting health awareness, with a focus on diet, and different measures to enhance health and social care have been launched. PN can be administered to children and infants who are sick or have a medical condition that necessitates particular nutritional care. According to Specialized Nutrition Europe (SNE), over 300,000 EU children are expected to require medical nutrition in early life stages for their particular medical demands, which supports growth and development. According to the study, roughly 40% of hospitalised adult patients are malnourished and require medical nutrition to manage their disease-related malnutrition, hence shortening their hospital stay. Parenteral nutrition reduces the risk of illness and underdevelopment, making it more widely adopted.

The Global Parenteral Nutrition Market is segmented based on the nutrition type and region. By Nutrition Type, the market is segmented into Single Dose Amino Acid Solution, Carbohydrates, Parenteral Lipid Emulsion, Trace Elements, and Vitamins & Minerals.

Regional Insights:

On region the Global Parenteral Nutrition Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.  North America dominated the overall global market, owing to presence of high research expenditure by government agencies and private entities in the healthcare sector, advanced medical devices and technologies, and collaborations among regulatory authorities, medical device industry, and universities. In addition, rising occurrence of several chronic diseases, existence of advanced healthcare facilities, as well as favorable reimbursement policies have led to an increase in the hospital admission that is anticipated to boost the usage rates in this region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Parenteral Nutrition Market report based on Nutrition Type and Region.

Global Parenteral Nutrition Market, By Region:

• North America
  • • • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global Parenteral Nutrition Market includes Actavis, Inc., Aculife, Healthcare Private Ltd. , Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Hospira, Inc., Grifols International S.A., Otsuka Pharmaceutical Factory, Inc., Sichuan Kelun Pharmaceutical Co. Ltd. and Vifor Pharma. Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global parenteral nutrition market. For instance, in July 2019, Baxter, a global leader in acute care has launched PrisMax in U.S. to maximize care for critically ill patients.

• Actavis, Inc.
• Aculife Healthcare Private Ltd.
• Baxter International, Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Hospira, Inc.
• Grifols International S.A.
• Otsuka Pharmaceutical Factory, Inc.
• Sichuan Kelun Pharmaceutical Co. Ltd.
• Vifor Pharma.